These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4148900)

  • 1. Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli.
    Then R
    Zentralbl Bakteriol Orig A; 1973 Oct; 225(1):34-41. PubMed ID: 4148900
    [No Abstract]   [Full Text] [Related]  

  • 2. The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo--I. Action of sulfonamides and trimethoprim in blood and urine.
    Then R; Angehrn P
    Biochem Pharmacol; 1974 Nov; 23(21):2977-82. PubMed ID: 4611429
    [No Abstract]   [Full Text] [Related]  

  • 3. Nature of trimethoprim-induced death in Escherichia coli.
    Angehrn P; Then R
    Arzneimittelforschung; 1973 Mar; 23(3):447-51. PubMed ID: 4575177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of bactericidal action of folic acid antagonists].
    Then R
    Zentralbl Bakteriol Orig A; 1974; 228(1):273-7. PubMed ID: 4154679
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergism between trimethoprim and sulfamethoxazole.
    Science; 1977 Sep; 197(4310):1300-1. PubMed ID: 331475
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiments to demonstrate a synergistic action between sulfonamides or trimethoprim and 5-fluro-2'-deoxyuridine against Escherichia coli.
    Then R
    Arzneimittelforschung; 1974 Dec; 24(12):1949-52. PubMed ID: 4281306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on synergistic behaviour and pharmacokinetics of the combination sulfonamide/trimethoprim. IV. A comparative study on potentiating the trimethoprim effect by various sulfonamides and critical observations on its dosing (author's transl)].
    Seydel JK; Wempe E
    Arzneimittelforschung; 1977; 27(8):1521-32. PubMed ID: 334187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations.
    Then RL
    Zentralbl Bakteriol A; 1980; 247(4):483-94. PubMed ID: 7006266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trimethoprim and its antagonists on RNA synthesis in Escherichia coli.
    Then R; Angehrn P
    Biochim Biophys Acta; 1972 Nov; 287(1):98-105. PubMed ID: 4569161
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 14. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
    Amyes SG
    Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kinetics.
    Seydel JK; Wempe E; Miller GH; Miller L
    J Infect Dis; 1973 Nov; 128():Suppl:463-9 p. PubMed ID: 4585952
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli.
    Seydel JK; Wempe E; Miller GH; Miller L
    Chemotherapy; 1972; 17(4):217-58. PubMed ID: 4557279
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations on the mode of action of the combination sulfamethoxazole-trimethoprim.
    Angehrn P; Then R
    Chemotherapy; 1973; 19(1):1-10. PubMed ID: 4583774
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae.
    Paisley JW; Washington JA
    Antimicrob Agents Chemother; 1978 Nov; 14(5):656-8. PubMed ID: 365085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole. Comparison of synergistic combinations.
    Griffith RS
    J Infect Dis; 1973 Nov; 128():Suppl:545-6. PubMed ID: 4585957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.